/C O R R E C T I O N -- Menarini Silicon Biosystems/

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Menarini-technology

More Like This

PR Newswire associated0

Menarini Silicon Biosystems announces publication of the DETECT III trial results highlighting the potential clinical utility of HER2 testing in circulating tumor cells with CELLSEARCH

PR Newswire associated0

Menarini Silicon Biosystems announces new study results on use of CELLSEARCH® liquid biopsy for earlier detection of relapse and to help inform decisions on patient management in stage III Melanoma

PR Newswire associated0

A. Menarini Diagnostics and Nucleix announce a strategic partnership for a non-invasive bladder cancer test in Europe

PR Newswire associated0

AI Diagnostic Platform Company Noul Enters Cancer Diagnostic Business with the Launch of Cervical Cell Analysis Product

MEGAROBO Unveils High-Content Cell Imaging System for Advanced Multidimensional Biological Analysis

Mursla Bio Presents Breakthrough Liquid Biopsy Technology for Extracellular Vesicles in Cell Press

Vector Laboratories and Navinci Diagnostics Announce Strategic Collaboration to Develop Novel Spatial Proteomic Tools Enabling Biomarker Discovery

PR Newswire associated0

CELLSEARCH® CTC count proves its clinical utility in guiding therapeutic strategy supporting patient care in HR+/HER2- metastatic breast cancer